Introduction:
=============

Amino acids have proven to play a significant role in the synthesis of novel drug candidates with the use of non-proteinogenic and unnatural amino acids \[[@B1-molecules-10-01218],[@B2-molecules-10-01218],[@B3-molecules-10-01218],[@B4-molecules-10-01218],[@B5-molecules-10-01218],[@B6-molecules-10-01218],[@B7-molecules-10-01218],[@B8-molecules-10-01218]\]. Recently a series of novel diflunisal hydrazide-hydrazone derivatives have demonstrated significant antimicrobial activity \[[@B9-molecules-10-01218]\]. These synthesized compounds and additional hydrazide derivatives were screened for their wide range of biological activities, antimycobacterial activity against *Mycobacterium tuberculosis*, antimicrobial activities against various bacteria (*Escherichia coli* and *Bacillus subtilis*), fungi, and yeast species \[[@B10-molecules-10-01218],[@B11-molecules-10-01218],[@B12-molecules-10-01218],[@B13-molecules-10-01218]\]. In addition, nicotinamide and nicotinic acid have been in use for 65 years due to their unusual antimicrobial spectrum. Many drugs possess modified pharmacological and toxicological properties when administered in form of metallic complexes \[[@B14-molecules-10-01218],[@B15-molecules-10-01218],[@B16-molecules-10-01218]\]. In view of this it was interesting to synthesize several new compounds to evaluate the effect of amino acids on the bioactivity of both benzoic acid hydrazide and nicotinic acid hydrazide. It was also of interest to study the effect of metals such as Cu and Cd on the antibacterial activity of these compounds, thus both hydrazide ligands and complexes were tested for their antibacterial and antifungal activity.

Results and Discussion
======================

Chemistry
---------

For the synthesis of the desired compounds, the sequence of reactions shown in [Scheme 1](#molecules-10-01218-f001){ref-type="scheme"} was followed. The reaction of benzoic acid hydrazide (**3**) with different N-Boc-L-amino acids in dimethylformamide in the presence of triethylamine (Et~3~N) as a base and N-\[(dimethylamino)-1H-1,2,3-triazolo\[4,5-b\]pyridin-1-yl-methyl-ene\]-N-methylmethanaminium hexafluorophsphate N-oxide (HATU) as coupling reagent at 0°C gave the desired compounds **5a-5e**. The structures of compounds **5a-5e** were established by means of IR, ^1^H-NMR, ^13^C-NMR, and elemental analyses. The infrared spectra of these compounds showed the absorption peaks of the urethane and the amide carbonyls in the 1715-1727 cm^-1^ and 1663-1693 cm^-1^ ranges, respectively, and the absorption peak of the N-H in the 3226-3336 cm^-1^ range. The ^1^H-NMR showed the presence of three exchangeable signals for the NH and the ^13^C-NMR detected the presence of one urethane carbonyl and two amide carbonyls in the 153-173 ppm range. Similarly, nicotinic acid hydrazide (**4**) was allowed to react under the same conditions with the same N-Boc-L-amino acids to give the desired compounds **6a-6e**. The structures of compounds **6a-6e** were also established by means of IR, ^1^H-NMR, ^13^C-NMR, and elemental analyses. Compounds **5** and **6** were subjected to N-deprotection by passing HCl gas into a solution of these compounds in methylene chloride/ether. The latter series upon deprotection of Boc group afforded the new series of compounds **7** and **8** ([Table 1](#molecules-10-01218-t001){ref-type="table"}, [Table 2](#molecules-10-01218-t002){ref-type="table"}).

Compounds **5**, **6**, **7** and **8** were allowed to undergo complexation with Cu and Cd. All complexes were obtained by reacting one equivalent of the ligands **5**, **6**, **7** or **8** once with 2 equivalents of Cu(NO~3~)~2~ and once with 2 equivalents of Cd(CH~3~COO)~2~ in methanol.

The Cu and Cd complexes were later decomposed and their Cu and Cd contents were analyzed by atomic absorption to determine the ratio of complex formation of Cu and Cd to ligand. The atomic absorption analysis showed the formation of complexes Cu:L and Cd:L in the ratio (1:1).

![](molecules-10-01218-g001){#molecules-10-01218-f001}

molecules-10-01218-t001_Table 1

###### 

Yields, Color, Mps., and Elemental Analyses of Compounds **7** and **8**.

  Cmpd         Yield (%)   Color   mp (°C)   Elemental Analysis (Found)                                      
  ------------ ----------- ------- --------- ------------------------------- ------------------------------- -------------------------------
  **7a**       75          White   244       53.04(52.89)                    6.68 (6.83)                     15.46(15.62)
  **7b**       84          White   155       58.24(58.39)                    5.66 (5.89)                     10.72(10.96)
  **7c**       93          White   190       54.64(54.91)                    7.05 (7.32)                     14.70(14.95)
  **7d**       83          White   238       60.09(59.84)                    5.67 (5.92)                     13.14(13.32)
  **7e**       89          White   233       64.86(64.58)                    5.68 (5.89)                     9.87 (9.59)
  **8a^\*^**   77          White   290       \-\-\-\-\-\-\-\-\-\-\-\-\-\--   \-\-\-\-\-\-\-\-\-\-\-\-\-\--   \-\-\-\-\-\-\-\-\-\-\-\-\-\--
  **8b^\*^**   81          White   267       \-\-\-\-\-\-\-\-\-\-\-\-\-\--   \-\-\-\-\-\-\-\-\-\-\-\-\-\--   \-\-\-\-\-\-\-\-\-\-\-\-\-\--
  **8c^\*^**   78          White   253       \-\-\-\-\-\-\-\-\-\-\-\-\-\--   \-\-\-\-\-\-\-\-\-\-\-\-\-\--   \-\-\-\-\-\-\-\-\-\-\-\-\-\--
  **8d^\*^**   89          White   215       \-\-\-\-\-\-\-\-\-\-\-\-\-\--   \-\-\-\-\-\-\-\-\-\-\-\-\-\--   \-\-\-\-\-\-\-\-\-\-\-\-\-\--
  **8e^\*^**   96          White   197       \-\-\-\-\-\-\-\-\-\-\-\-\-\--   \-\-\-\-\-\-\-\-\-\-\-\-\-\--   \-\-\-\-\-\-\-\-\-\-\-\-\-\--

^\*^ = Elemental analysis was unreliable due to their hygroscopic nature.

molecules-10-01218-t002_Table 2

###### 

^1^H-NMR Data of Compounds **7** and **8**.

  Compound   ^1^H-NMR (DMSO-d~6~): (δ) ppm
  ---------- -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  **7a**     0.89, 0.97 (2d, 6H, 2 CH~3~), 1.92 (m, 1H, CH), 4.89 (d, 1H, CH), 7.40-7.88 (m, 5H, aromatic), 8.38 (br.s, 2H, 2 NH), 10.64 (br.s, 2H, 2 NH).
  **7b**     1.99 (m, 2H, CH~2~), 2.63, 2.75 (2m, 2H, CH~2~-CO), 4.55 (m, 1H, CH), 5.14 m, 2H, CH~2~-O), 7.21-7.90 (m, 10H, aromatic), 8.36 (br.s, 2H, 2 NH), 10.66 (br.s, 2H, 2 NH).
  **7c**     0.91 (dd, 6H, 2 CH~3~), 1.63 (m, 2H, CH~2~), 1.81 (m, 1H, CH), 3.83 (m, 1H, CH), 7.46-7.87 (m, 5H, aromatic), 8.42 (br.s, 2H, 2 NH), 10.61 (br.s, 2H, 2 NH).
  **7d**     3.07 (2m, 2H, CH~2~), 4.16 (m, 1H, CH), 7.22-7.89 (m, 10H, aromatic), 8.34 (br.s, 2H, 2 NH), 10.65 (br.s, 2H, 2 NH).
  **7e**     3.08 (m, 2H, CH~2~), 4.29 (m, 1H, CH), 5.11 (br.s, 2H, CH~2~), 7.24-7.96 (m, 14H, aromatic), 8.45 (br.s, 2H, 2 NH), 10.59 (br.s, 2H, 2 NH).
  **8a**     δ 0.87, 0.96 (2d, 6H, 2 CH~3~), 1.96 (m, 1H, CH), 4.01 (m, 1H, CH), 7.79 (d, 2H, aromatic), 8.40 (br.s, 2H, 2 NH), 8.78 (d, 2H, aromatic), 10.62 (br.s, 2H, 2 NH).
  **8b**     2.03 (m, 2H, CH~2~), 2.35 (m, 2H, CH~2~-CO), 4.09 (m, 1H, CH), 5.14 m, 2H, CH~2~-O), 7.33-7.82 (m, 7H, aromatic), 8.44 (br.s, 2H, 2 NH), 8.77 (d, 2H, aromatic), 10.66 ( br.s, 2H, 2 NH).
  **8c**     δ 0.92 (d, 6H, 2 CH~3~), 1.59 (m, 2H, CH~2~), 1.79 (m, 1H, CH), 4.07 (m, 1H, CH), 7.79 (d, 2H, aromatic), 8.39 (br.s, 2H, 2 NH), 8.75 (d, 2H, aromatic), 10.71 (br.s, 2H, 2 NH).
  **8d**     3.09 (m, 2H, CH~2~), 4.33 (m, 1H, CH), 7.25-7.39 (m, 5H, aromatic), 7.85 (d, 2H, aromatic), 8.43 (br.s, 2H, 2 NH), 8.79 (d, 2H, aromatic), 10.79 (br.s, 2H, 2 NH).
  **8e**     3.04 (m, 2H, CH~2~), 4.27 (m, 1H, CH), 5.14 (br.s, 2H, CH~2~), 7.24-7.47 (m, 9H, aromatic), 7.82 (d, 2H, aromatic), 8.45 (br.s, 2H, 2 NH), 8.79 (d, 2H, aromatic), 10.62 (m, 2H, 2 NH);

Biological Test Results
-----------------------

The synthesized compounds **5**, **6**, **7** and **8** and their **Cu** and **Cd** complexes have been evaluated for their antimicrobial activity. The microdilution susceptibility test in Müller-Hinton Broth (Oxoid) and Sabouraud Liquid Medium (Oxoid) were used for the determination of antibacterial and antifungal activity \[[@B17-molecules-10-01218]\]. The minimal inhibitory concentration (MIC) values listed in [Table 3](#molecules-10-01218-t003){ref-type="table"} show that all the test compounds have lower antifungal activity than clotrimazole (Canesten^®^, Bayer).

molecules-10-01218-t003_Table 3

###### 

Minimal inhibitory concentration (MIC) of test compounds in μg/mL.

  Test compound            E. coli         S. aureus         C. albicans         Test compound            E. coli   S. aureus   C. albicans
  ------------------------ --------------- ----------------- ------------------- ------------------------ --------- ----------- -------------
  **ampicillin**           25              12.5              \-\-\-\-\-\-\-\--   **(Cu:L),(1:1) of 6e**   100       **12.5**    200
  **clotrimazole**         \-\-\-\-\-\--   \-\-\-\-\-\-\--   12.5                **(Cd:L),(1:1) of 5a**   100       \>200       \>200
  **5a**                   \>200           \>200             \>200               **(Cd:L),(1:1) of 5b**   \>200     **25**      \>200
  **5b**                   \>200           \>200             \>200               **(Cd:L),(1:1) of 5c**   \>200     \>200       \>200
  **5c**                   100             100               \>200               **(Cd:L),(1:1) of 5d**   \>200     **25**      \>200
  **5d**                   **50**          \>200             \>200               **(Cd:L),(1:1) of 5e**   \>200     \>200       \>200
  **5e**                   \>200           \>200             \>200               **(Cd:L),(1:1) of 6a**   \>200     \>200       \>200
  **6a**                   \>200           \>200             \>200               **(Cd:L),(1:1) of 6b**   \>200     100         \>200
  **6b**                   **100**         \>200             \>200               **(Cd:L),(1:1) of 6c**   100       \>200       \>200
  **6c**                   **50**          \>200             \>200               **(Cd:L),(1:1) of 6d**   \>200     \>200       \>200
  **6d**                   100             \>200             \>200               **(Cd:L),(1:1) of 6e**   100       \>200       \>200
  **6e**                   **50**          \>200             \>200               **(Cu:L),(1:1) of 7a**   \>200     \>200       \>200
  **7a**                   100             100               \>200               **(Cu:L),(1:1) of 7b**   \>200     \>200       \>200
  **7b**                   **25**          \>200             \>200               **(Cu:L),(1:1) of 7c**   \>200     100         \>200
  **7c**                   100             50                \>200               **(Cu:L),(1:1) of 7d**   \>200     50          \>200
  **7d**                   100             \>200             \>200               **(Cu:L),(1:1) of 7e**   \>200     50          \>200
  **7e**                   200             50                \>200               **(Cu:L),(1:1) of 8a**   \>200     \>200       \>200
  **8a**                   **25**          \>200             \>200               **(Cu:L),(1:1) of 8b**   \>200     \>200       \>200
  **8b**                   100             100               \>200               **(Cu:L),(1:1) of 8c**   \>200     \>200       \>200
  **8c**                   **50**          \>200             \>200               **(Cu:L),(1:1) of 8d**   100       \>200       \>200
  **8d**                   100             100               \>200               **(Cu:L),(1:1) of 8e**   \>200     100         \>200
  **8e**                   **50**          100               \>200               **(Cd:L),(1:1) of 7a**   100       \>200       \>200
  **(Cu:L),(1:1) of 5a**   200             100               \>200               **(Cd:L),(1:1) of 7b**   \>200     \>200       \>200
  **(Cu:L),(1:1) of 5b**   \>200           \>200             100                 **(Cd:L),(1:1) of 7c**   100       **12.5**    \>200
  **(Cu:L),(1:1) of 5c**   100             50                \>200               **(Cd:L),(1:1) of 7d**   **50**    \>200       \>200
  **(Cu:L),(1:1) of 5d**   \>200           50                \>200               **(Cd:L),(1:1) of 7e**   \>200     \>200       \>200
  **(Cu:L),(1:1) of 5e**   200             **25**            \>200               **(Cd:L),(1:1) of 8a**   \>200     \>200       \>200
  **(Cu:L),(1:1) of 6a**   \>200           100               \>200               **(Cd:L),(1:1) of 8b**   100       \>200       \>200
  **(Cu:L),(1:1) of 6b**   \>200           \>200             \>200               **(Cd:L),(1:1) of 8c**   \>200     \>200       \>200
  **(Cu:L),(1:1) of 6c**   \>200           \>200             \>200               **(Cd:L),(1:1) of 8d**   100       \>200       \>200
  **(Cu:L),(1:1) of 6d**   200             100               \>200               **(Cd:L),(1:1) of 8e**   \>200     \>200       \>200

The test compounds are more active against *S. aureus* and *E. coli.* Compounds **(Cu:L),(1:1)** of **6e** and **(Cd:L),(1:1)** of **7c** have antimicrobial activity against *S. aureus* comparable to that of ampicillin, while the activity of compounds **(Cu:L),(1:1)** of **5e**, **(Cd:L),(1:1)** of **5b** and **(Cd:L),(1:1)** of **5d** is about 50% of that of ampicillin. Compounds **7b** and **8a** have antimicrobial activity against *E. coli* comparable to that of ampicillin, while the activity of compounds **5d**, **6c**, **6e**, **8c**, **8e**, **(Cd:L),(1:1)** of **7d** is about 50% of that of ampicillin.

Conclusions
===========

The present work describes the synthesis of amino acid derivatives and its metal complexes which showed interesting results comparable to ampicillin. The uncomplexed compounds showed higher antimicrobial activity against *E. coli* compared to their respective complexes. While the complexes showed higher antimicrobial activity against *S. aureus* compared to their respective ligands. These results prompted us to further pursue in SAR as our future plane.

Experimental
============

General
-------

Melting points were determined on a Mel-Temp apparatus and are uncorrected. ^1^H-NMR and ^13^C-NMR spectra were recorded on a Bruker 300 MHz spectrometer with chemical shift values reported in δ units (ppm) relative to an internal standard (tetramethylsilane). Infrared data were obtained on a Perkin-Elmer 1600 series Fourier transform instrument as KBr pellets. Amino acids are abbreviated and designated following the rules of the IUPAC-IUB Commission of Biochemical *Nomenclature (J. Biol. Chem.,* **1972**, *247*, 977*).* The abbreviations: HATU (N-\[(dimethylamino)-1H-1,2,3-triazolo\[4,5-b\]pyridin-1-ylmethylene\]-N-methyl-methanaminium hexafluorophosphate N-oxide); Boc (*t*-butyloxy-carbonyl); Et~3~N (triethylamine) and DMF (N,N-dimethylformamide) were used throughout the manuscript. Follow up of the reactions and checking the homogeneity of the compounds were made by TLC on silica gel-protected aluminum sheets (Type 60 F254, Merck) and the spots were detected by exposure to UV-lamp at λ 254 nm for few seconds. Elemental analyses were performed in the Chemistry Department, Faculty of Science, Cairo, University.

Chemistry
---------

General Procedure for the Reaction of N-Boc-L-Amino Acids with Benzoic Acid Hydrazide.
--------------------------------------------------------------------------------------

A mixture of *N*-Boc-L-amino acid (1 mmol), HATU (0.38 g, 1 mmol) and Et~3~N (0.28 mL, 2 mmol) was stirred at 0°C for 3 minutes in DMF (2 mL). Then benzoic acid hydrazide (**3**, 0.122 g, 1 mmol) was added. The reaction mixture was stirred at 0°C for 1 hour and left overnight at room temperature. The reaction mixture was diluted with ethyl acetate (80 mL) and the mixture was washed successively with 5% aqueous citric acid solution (2°10 mL), saturated sodium bicarbonate solution (2°10 mL) and saturated sodium chloride solution (2°10 mL). The organic layer was dried over anhydrous sodium sulphate, filtered and the solvent was removed *in vacuo*. The crude product was crystallized from methylene chloride-hexane. In the case of *N*-Boc L-(O-benzyl)-tyrosine (**5e**) and *N*-Boc-L-phenylalanie (**5d**) the reaction mixture was poured into ice water, filtered, washed with 5% aqueous citric acid solution, saturated sodium bicarbonate solution and finally with water, dried and recrystallized from methylene chloride-hexane.

*Boc-valyl(N\`-benzoyl)-hydrazide* (**5a**): White crystals, 0.32 g (95.4 % yield); mp 156-157°C; IR: 3308, 3226 (NH), 1715 (C=O, urethane), 1689 (C=O, amide), 1668 (C=O, amide) cm^-1^; ^1^H-NMR (CDCl~3~): δ 0.87, 0.95 (2d, 6H, 2 CH~3~), 1.35 (s, 9H, 3 CH~3~), 1.88 (m, 1H, CH), 4.93 (d, 1H, CH), 7.20-7.77 (m, 6H, 1 NH, aromatic), 9.17, 9.34 (2 br.s, 2H, 2 NH); ^13^C-NMR (CDCl~3~): δ 19.61, 19.70, 26.40, 28.62, 50.49, 80.69, 127.40, 129.00, 129.71, 131.79, 132.70, 136.58, 156.00, 164.62, 169.01; *Anal.* Calcd for C~17~H~25~N~3~O~4~: C, 60.88; H, 7.51; N, 12.53. Found: C, 60.72; H, 7.68; N, 12.81.

*Boc-(o-benzyl)-glutamyl(N\`-benzoyl)-hydrazide* (**5b**): White powder, 0.38 g (80 % yield); mp 126°C; IR: 3336, 3253 (NH), 1753 (C=O, ester), 1727 (C=O, urethane), 1686 (C=O, amide), 1663 (C=O, amide) cm^-1^; ^1^H-NMR (CDCl~3~): δ 1.37 (s, 9H, 3 CH~3~), 1.90, 2.05 (2m, 2H, CH~2~), 2.60, 2.71 (2m, 2H, CH~2~-CO), 4.50 (m, 1H, CH), 5.15 m, 2H, CH~2~-O), 7.20-7.81 (m, 11H, 1 NH, aromatic), 9.17, 9.34 (2 br.s, 2H, 2 NH); ^13^C-NMR (CDCl~3~): δ 24.96, 28.16, 28.67, 49.70, 66.94, 80.72, 127.79, 128.65, 128.94, 128.95, 129.02, 131.87, 132.69, 136.10, 136.16, 153.64, 165.20, 169.82, 173.20; *Anal.* Calcd for C~24~H~29~N~3~O~6~: C, 63.28; H, 6.42; N, 9.22. Found: C, 63.02; H, 6.21; N, 8.96.

*Boc-leucyl(N\`-benzoyl)-hydrazide* (**5c**): White crystals, 0.26 g (74 % yield); mp 147°C; IR: 3318, 3234 (NH), 1726 (C=O, urethane), 1689 (C=O, amide), 1672 (C=O, amide) cm^-1^; ^1^H-NMR (DMSO-d~6~): δ 0.91 (d, 6H, 2 CH~3~), 1.38 (s, 9H, 3 CH~3~), 1.51 (m, 2H, CH~2~), 1.72 (m, 1H, CH), 4.12 (m, 1H, CH), 6.85 (d, 1H, 1 NH), 7.2-7.77 (m, 5H, aromatic), 10.10, 10.40 (2 br.s, 2H, 2 NH); ^13^C-NMR (DMSO-d~6~): δ 21.88, 23.00, 23.29, 24.47, 28.54, 51.64, 79.20, 126.00, 127.50, 131.65, 153.65, 156.11, 171.15; *Anal.* Calcd for C~18~H~27~N~3~O~4~: C, 61.87; H, 7.79; N, 12.03. Found: C, 62.05; H, 7.92; N, 12.26.

*Boc-phenylalanyl(N\`-benzoyl)-hydrazide* (**5d**): White powder, 0.31 g (81 % yield); mp 168°C; IR: 3314, 3233 (NH), 1725 (C=O, urethane), 1692 (C=O, amide), 1673 (C=O, amide) cm^-1^; ^1^H-NMR (DMSO-d~6~): δ 1.30 (s, 9H, 3 CH~3~), 2.82, 3.08 (2m, 2H, CH~2~), 4.30 (m, 1H, CH), 7.04 (d, 1H, 1 NH), 7.18-7.92 (m, 10H, aromatic), 10.18, 10.29 (2 br.s, 2H, 2 NH); ^13^C-NMR (DMSO-d~6~): δ 28.50, 37.68, 54.85, 126.58, 127.80, 128.40, 128.81, 129.59, 132.18, 153.62, 164.9, 173.10; *Anal.* Calcd for C~21~H~25~N~3~O~4~: C, 65.78; H, 6.57; N, 10.96. Found: C, 65.98; H, 6.78; N, 10.71.

*Boc-(o-benzyl)-tyrosyl(N\`-benzoyl)-hydrazide* (**5e**): White crystals, 0.47 g (96 % yield); mp 177°C; IR: 3322, 3245 (NH), 1726 (C=O, urethane), 1693 (C=O, amide), 1673 (C=O, amide) cm^-1^; ^1^H-NMR (DMSO-d~6~): δ 1.31 (s, 9H, 3 CH~3~), 2.85, 3.05 (2m, 2H, CH~2~), 4.25 (m, 1H, CH), 5.05 (br.s, 2H, CH~2~), 6.92-7.93 (m, 15H, aromatic, 1NH), 10.15, 10.46 (2s, 2H, 2 NH); ^13^C-NMR (DMSO-d~6~): δ 26.52, 32.01, 53.48, 68.50, 77.52, 112.81, 125.90, 126.02, 126.81, 128.69, 130.21, 135.6, 153.62, 155.04, 163.81, 170.00; *Anal.* Calcd for C~28~H~31~N~3~O~5~: C, 68.69; H, 6.38; N, 8.58. Found: C, 68.51; H, 6.15; N, 8.73.

General Procedure for the Reaction of N-Boc-L-Amino Acids with Nicotinic Acid Hydrazide.
----------------------------------------------------------------------------------------

A mixture of N-Boc-L-amino acid (1 mmol), HATU (0.38 g, 1 mmol) and Et~3~N (0.15 mL, 1 mmol) was stirred at 0°C for 3 minutes in DMF (2 mL). Then nicotinic acid hydrazide (**4**, 0.123 g, 1 mmol) was added. The reaction mixture was stirred at 0°C for 1 hour and left overnight at room temperature. The reaction mixture was diluted with methylene chloride (80 mL) and the mixture was washed with 5% aqueous citric acid solution (2°10 mL), saturated sodium bicarbonate solution (2°10 mL) and saturated sodium chloride solution (2°10 mL). The organic layer was dried over anhydrous sodium sulphate, filtered and the solvent was removed *in vacuo*. The crude product was crystallized from methylene chloride-hexane.

*Boc-valyl(N\`-nicotinoyl)-hydrazide* (**6a**): White crystals, 0.28 g (83.3 % yield); mp 209°C; IR: 3344, 3242 (NH), 1726 (C=O, urethane), 1708 (C=O, amide), 1661 (C=O, amide) cm^-1^; ^1^H-NMR (DMSO-d~6~): δ 0.86, 0.94 (2d, 6H, 2 CH~3~), 1.39 (s, 9H, 3 CH~3~), 1.96 (m, 1H, CH), 3.93 (m, 1H, CH), 6.81 (d, 1H, 1 NH), 7.77 (d, 2H, aromatic), 8.75 (d, 2H, aromatic), 10.12, 10.68 (2 br.s, 2H, 2 NH); ^13^C-NMR (DMSO-d~6~): δ 18.7, 19.5, 28.6, 30.7, 58.7, 78.4, 121.7, 139.8, 150.7, 155.7, 164.1, 171.1; *Anal.* Calcd for C~16~H~24~N~4~O~4~: C, 57.13; H, 7.19; N, 16.66. Found: C, 57.34; H, 7.35; N, 16.41.

*Boc-(o-benzyl)-glutamyl(N\`-nicotinoyl)-hydrazide* (**6b**): White powder, 0.42 g (92 % yield); mp 120°C; IR: 3334, 3243 (NH), 1740 (C=O, ester), 1727 (C=O, urethane), 1681 (C=O, amide) cm^-1^; ^1^H-NMR (DMSO-d~6~): δ 1.38 (s, 9H, 3 CH~3~), 1.84, 2.04 (2m, 2H, CH~2~), 2.32 (m, 2H, CH~2~-CO), 4.07 (m, 1H, CH), 5.14 m, 2H, CH~2~-O), 7.02 (m, 1H, 1 NH), 7.34 (br.s, 5H, aromatic), 7.77 (d, 2H, aromatic), 8.75 (d, 2H, aromatic), 10.13, 10.66 (2 br.s, 2H, 2 NH); ^13^C-NMR (DMSO-d~6~): δ 26.6, 28.3, 30.0, 53.6, 66.2, 78.7, 121.6, 128.1, 128.4, 128.5, 128.7, 136.3, 139.7, 150.8, 156.0, 164.3, 171.1, 172.6, 175.8; *Anal.* Calcd for C~23~H~28~N~4~O~6~: C, 60.52; H, 6.18; N, 12.27. Found: C, 60.37; H, 6.32; N, 12.45.

*Boc-leucyl(N\`- nicotinoyl)-hydrazide* (**6c**): White crystals, 0.25 g (71.3 % yield); mp 210°C; IR: 3301, 3222 (NH), 1710 (C=O, urethane), 1662 (C=O, amide) cm^-1^; ^1^H-NMR (DMSO-d~6~): δ 0.91 (d, 6H, 2 CH~3~), 1.38 (s, 9H, 3 CH~3~), 1.53 (m, 2H, CH~2~), 1.72 (m, 1H, CH), 4.13 (m, 1H, CH), 6.85 (d, 1H, 1 NH), 7.77 (d, 2H, aromatic), 8.71 (d, 2H, aromatic), 10.10, 10.70 (2 br.s, 2H, 2 NH); ^13^C-NMR (DMSO-d~6~): δ 21.88, 23.00, 23.29, 24.47, 28.54, 51.64, 78.75, 121.64, 139.77, 150.48, 155.55, 163.97, 172.38; *Anal.* Calcd for C~17~H~26~N~4~O~4~: C, 58.27; H, 7.48; N, 15.99. Found: C, 58.02; H, 7.21; N, 16.26.

*Boc-phenylalanyl(N\`-nicotinoyl)-hydrazide* (**6d**): White powder, 0.29 g (75.4 %) yield, mp 145°C; IR: 3309, 3234 (NH), 1726 (C=O, urethane), 1695 (C=O, amide), 1677 (C=O, amide) cm^-1^; ^1^H-NMR (DMSO-d~6~): δ 1.29 (s, 9H, 3 CH~3~), 2.82, 3.07 (2m, 2H, CH~2~), 4.31 (m, 1H, CH), 7.05-7.37 (m, 6H, aromatic, 1 NH), 7.81 (d, 2H, aromatic), 8.76 (d, 2H, aromatic), 10.33, 10.82 (2 br.s, 2H, 2 NH)); ^13^C-NMR (DMSO-d~6~): δ 28.12, 28.48, 37.82, 54.87, 78.4, 121.68, 126.62, 128.42, 129.57, 138.30, 139.70, 150.77, 155.67, 164.18, 171.70; *Anal.* Calcd for C~20~H~24~N~4~O~4~: C, 62.49; H, 6.29; N, 14.57. Found: C, 62.65; H, 6.50; N, 14.83.

*Boc-(o-benzyl)-tyrosyl(N\`-nicotinoyl)-hydrazide* (**6e**): White crystals, 0.38 g (77.5 %) yield, mp 141°C; IR: 3311, 3237 (NH), 1727 (C=O, urethane), 1695 (C=O, amide), 1677 (C=O, amide) cm^-1^; ^1^H-NMR (DMSO-d~6~): δ 1.33 (s, 9H, 3 CH~3~), 2.83, 3.05 (2m, 2H, CH~2~), 4.26 (m, 1H, CH), 5.10 (br.s, 2H, CH~2~), 6.96-7.47 (m, 10H, aromatic, 1NH), 7.83 (d, 2H, aromatic), 8.78 (d, 2H, aromatic),10.36, 10.63 (2m, 2H, 2 NH); ^13^C-NMR (DMSO-d~6~): δ 28.20, 28.54, 37.03, 55.19, 69.50, 78.38, 114.77, 121.70, 127.99, 128.77, 130.63, 137.60, 140.06, 150.72, 155.68, 157.32, 164.08, 171.64; *Anal.* Calcd for C~27~H~30~N~4~O~5~: C, 66.11; H, 6.16; N, 11.42. Found: C, 65.82; H, 5.95; N, 11.59.

General Procedure for the Preparation of the Hydrochloride Salts ***7*** and ***8***.
-------------------------------------------------------------------------------------

**5** or **6** (1 mmol) were dissolved in a mixture of methylene chloride (4 mL) and ether (4 mL). HCl gas was passed through the solution for 2 hours. A white precipitate that formed was filtered and washed with anhydrous ether. The crude product was recrystallized from methyl alcohol-anhydrous ether to give white crystals. The amino acid-(*N*\`- nicotinoyl) hydrazide hydrochloride salts **8a-8e** were obtained as hygroscopic salts.

General Procedure for the Preparation of the Cu Complexes.
----------------------------------------------------------

A solution of Cu(NO~3~)~2~ (0.48 gm, 2 mmol) in methyl alcohol (2 mL) was added to a solution of **5**, **6**, **7** or **8** (1 mmol) in methyl alcohol (4 mL). A change was observed in the color of the solution. The Cu complexes were obtained as green crystals. The Cu complexes were later decomposed and their Cu content was analyzed by atomic absorption to determine the ratio of complex formation of Cu to ligand. The atomic absorption analysis showed the formation of complexes Cu:L in the ratio (1:1).

General Procedure for the Preparation of the Cd Complexes
---------------------------------------------------------

A solution of Cd(CH~3~COO)~2~ (0.46 gm, 2 mmol) in methyl alcohol (2 mL) was added to a solution of **5**, **6**, **7** or **8** (1 mmol) in methyl alcohol (4 mL). The Cd complexes were obtained as white crystals. The Cd complexes were later decomposed and their Cd content was analyzed by atomic absorption to determine the ratio of complex formation of Cd to ligand. The atomic absorption analysis showed the formation of complexes Cd:L in the ratio (1:1).

In vitro antimicrobial activity
-------------------------------

The microdilution susceptibility test in Müller-Hinton Broth (Oxoid) and Sabouraud Liquid Medium (Oxoid) were used for the determination of antibacterial and antifungal activity \[[@B17-molecules-10-01218],[@B18-molecules-10-01218]\]. The utilized test organisms were: *Escherichia coli* (*E. coli*) ATCC 25922 as an example of Gram-negative bacteria, *Staphylococcus aureus* (*S. aureus*) ATCC 19433 as an example of Gram-positive bacteria and *Candida albicans* (*C. albicans*) as yeast-like fungi. Ampicillin trihydrate and clotrimazole were used as standard antibacterial and antifungal agents, respectively. Solutions of the test compounds, ampicillin trihydrate and clotrimazole were prepared in DMSO to a concentration of 1600 μg/mL. Twofold dilutions of the compounds were prepared (800, 400, ... 6.25 μg/mL). Microorganism suspensions at 10^6^ CFU/mL (Colony Forming Unit/mL) concentrations were inoculated to the corresponding wells. Plates were incubated at 36°C for 24 h to 48 h. The incubation chamber was kept sufficiently humid. At the end of the incubation period, the minimal inhibitory concentrations (MIC) were determined.

Author is very grateful to Dr. Adnan A. Bekhit, Department of Pharmaceutical Chemistry, and Dr. Elsayed Aboulmagd, Department of Microbiology, Faculty of Pharmacy, University of Alexandria, Egypt; for performing the antimicrobial evaluation.
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